Top Markets
Coin of the day
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Rank in Stocks #18445
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Share Price
$0.27824149
Market Cap
$198.06M
Change (1 day)
-1.24%
Change (1 year)
-11.01%
Country
TW
Trade TaiGen Biopharmaceuticals Holdings Limited (4157)

Category

Stock price history for TaiGen Biopharmaceuticals Holdings Limited (4157)
Highest end of day price: $0.28 on 2026-09-01

Lowest end of day price: $1.49 on 2013-08-01
Stock price history of TaiGen Biopharmaceuticals Holdings Limited from 2013 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -13.76%
2025 8.10%
2024 -28.68%
2023 -6.08%
2022 -5.50%
2021 -30.39%
2020 28.90%
2019 10.79%
2018 -22.39%
2017 -18.30%
2016 -14.71%
2015 -14.32%
2014 -40.68%
2013 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.10 -8.92%
AU
$757.71 6.76%
CH